Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01701999Phase 2Completed
A Phase 2 trial of recombinant botulinum vaccine A/B in botulism, sponsored by California Department of Public Health. Started Feb 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01701999.